Webinar - Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form

In this webinar, we will cover:
1. An overview of therapeutic antibodies, focusing on the opportunities and challenges of current monotherapy.
2. The major benefits of bispecific antibodies and the current formats used in clinical trails.
3. An in depth , integrated SMAB (single-domain antibody fused to monoclonal antibody) case study from rational design to preclinical development.